CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT By and Between Oramed Ltd. and Integrium, LLC Effective Date: January 15, 2020Clinical Research Organization Services Agreement • September 18th, 2020 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Oramed Ltd. (“Sponsor”), an Israeli company, with principal offices at Hi-Tech Park 2/4 Givat-Ram, P.O. Box 39098, Jerusalem, 91390, Israel and Integrium, LLC, (“Integrium”), a California limited liability company, located at 14351 Myford Road, Suite A, Tustin, California, 92780, hereby agree as follows:
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION; [***] DENOTES OMISSIONS** CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT By and...Clinical Research Organization Services Agreement • November 14th, 2014 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT By and Between...Clinical Research Organization Services Agreement • April 9th, 2018 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Oramed Ltd. (“Sponsor”), an Israeli company, with principal offices at Hi-Tech Park 2/4 Givat-Ram, P.O. Box 39098, Jerusalem, 91390, Israel and Integrium, LLC, (“Integrium”), a California limited liability company, located at 14351 Myford Road, Suite A, Tustin, California, 92780, hereby agree as follows:
